310 related articles for article (PubMed ID: 27556298)
21. The Pal3 promoter sequence is critical for the regulation of human renin gene transcription by peroxisome proliferator-activated receptor-gamma.
Todorov VT; Desch M; Schubert T; Kurtz A
Endocrinology; 2008 Sep; 149(9):4647-57. PubMed ID: 18483152
[TBL] [Abstract][Full Text] [Related]
22. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
[TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer.
Catalano S; Mauro L; Bonofiglio D; Pellegrino M; Qi H; Rizza P; Vizza D; Bossi G; Andò S
Am J Pathol; 2011 Aug; 179(2):1030-40. PubMed ID: 21704006
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis.
Chen HY; Clayman ES; Ma WF
J Interferon Cytokine Res; 2015 Oct; 35(10):771-8. PubMed ID: 25978539
[TBL] [Abstract][Full Text] [Related]
25. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells.
Chua AW; Hay HS; Rajendran P; Shanmugam MK; Li F; Bist P; Koay ES; Lim LH; Kumar AP; Sethi G
Biochem Pharmacol; 2010 Nov; 80(10):1553-62. PubMed ID: 20699088
[TBL] [Abstract][Full Text] [Related]
26. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration.
Lee BC; Lee TH; Zagozdzon R; Avraham S; Usheva A; Avraham HK
Cancer Res; 2005 Apr; 65(7):2840-5. PubMed ID: 15805285
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
[TBL] [Abstract][Full Text] [Related]
28. Involvement of insulin-like growth factor binding protein-3 in peroxisome proliferator-activated receptor gamma-mediated inhibition of breast cancer cell growth.
Pon CK; Firth SM; Baxter RC
Mol Cell Endocrinol; 2015 Jan; 399():354-61. PubMed ID: 25449421
[TBL] [Abstract][Full Text] [Related]
29. Identification of Nogo-B as a new molecular target of peroxisome proliferator-activated receptor gamma.
Yu M; Zhang S; Guo F; Yang X; Li Q; Wei Z; Han J; Duan Y; Chen Y
Cell Signal; 2020 Jan; 65():109429. PubMed ID: 31654717
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
[TBL] [Abstract][Full Text] [Related]
31. Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4/β-catenin/PPARδ signalling.
Wang Y; Lan W; Xu M; Song J; Mao J; Li C; Du X; Jiang Y; Li E; Zhang R; Wang Q
Cell Death Dis; 2021 Feb; 12(2):214. PubMed ID: 33637678
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor γ agonists induce cell cycle arrest through transcriptional regulation of Kruppel-like factor 4 (KLF4).
Li S; Zhou Q; He H; Zhao Y; Liu Z
J Biol Chem; 2013 Feb; 288(6):4076-84. PubMed ID: 23275339
[TBL] [Abstract][Full Text] [Related]
33. Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts.
Barone I; Vircillo V; Giordano C; Gelsomino L; Győrffy B; Tarallo R; Rinaldi A; Bruno G; Caruso A; Romeo F; Bonofiglio D; Andò S; Catalano S
Cancer Lett; 2018 Nov; 437():89-99. PubMed ID: 30176263
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells.
Zaytseva YY; Wang X; Southard RC; Wallis NK; Kilgore MW
Mol Cancer; 2008 Dec; 7():90. PubMed ID: 19061500
[TBL] [Abstract][Full Text] [Related]
35. Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.
Giordano C; Barone I; Vircillo V; Panza S; Malivindi R; Gelsomino L; Pellegrino M; Rago V; Mauro L; Lanzino M; Panno ML; Bonofiglio D; Catalano S; Andò S
Sci Rep; 2016 Feb; 6():21782. PubMed ID: 26899873
[TBL] [Abstract][Full Text] [Related]
36. A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.
Zhan Y; Zhang H; Li J; Zhang Y; Zhang J; He L
J Cell Mol Med; 2015 Jul; 19(7):1614-23. PubMed ID: 25753200
[TBL] [Abstract][Full Text] [Related]
37. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
Tang Q; Wu J; Zheng F; Hann SS; Chen Y
Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
[TBL] [Abstract][Full Text] [Related]
38. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
39. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
[TBL] [Abstract][Full Text] [Related]
40. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression.
Kim B; Park B
Biochemistry; 2014 Dec; 53(48):7562-9. PubMed ID: 25407882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]